Pooled Normal Human Serum from Innovative Research was recently used in the following study:
Journal of Molecular Medicine, September 2018
Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis
Yan Li, Fiona Clow, John D. Fraser, Feng LinJournal of Molecular Medicine, September 2018
" ... Recombinant SSL7 and SSL7-C5a SSL7 mutant lacking C5 binding activity were overexpressed in Escherichia coli and purified following the protocol described in previous reports [16, 20]. Pooled normal human serum (NHS) as the source of complement was purchased from Innovative Research (Novi, MI)."
